20 / 26
INDICATOR 1 (CMP.1): ADDITIONAL CAPACITY VOLUMES MADE
AVAILABLE THROUGH EACH CMP
As shown in Figure 1, FDA UIOLI is the CMP
mechanism that releases the most capacity – on
a cumulative basis for the period under consid-
eration – at congested IPs while the LT UIOLI
mechanism does not provide any additional ca-
pacity at congested IP sides to the market for the
observed period. The capacity volume released
through OS+BB is moderate in comparison with
FDA UIOLI and Surrender of Capacity.
Surrender of Capacity appears to be the most ef-
fective of all four CMPs for network users since
the ratio of allocated capacity relative to capaci-
ty on offer is close to 100%. This is due to the
fact that Surrender of Capacity in the allocation
process has, after available capacity, is first pri-
ority for yearly, quarterly and monthly products.
4 Results of Effect Monitoring
Exercise
OS + BB
FDA UIOLI
SURRENDER
LT UIOLI
ADDITIONAL CAPACITY
OFFERED
16.396 MWh/h/y
679.346 MWh/h/y
100.541 MWh/h/y
–
(RE)ALLOCATED CAPACITY
–
2.344 MMWh/h/y
93.041 MWh/h/y
–
RATIO
0%
0.35%
92.54%
–
OS + BB: Oversubscription and Buy-Back
FDA UIOLI: Firm Day-Ahead Use-It-Or-Lose-It
SURRENDER: Surrender of Capacity
LT UIOLI: Long-Term Use-It-Or-Lose-It
CMP Offered and Allocated Capacity
0
700 000
600 000
400 000
500 000
300 000
200 000
100 000
Offered
Allocated
16 395.68
679 346.10
100 541.20
2 344.21
–
–
–
93 040.82
OS + BB
FDA UIOLI
Surrender
LT UIOLI
Figure 1:
Results of CMP indicator 1
20 |
ENTSOG CMP Monitoring Report 2016